CYP 2.44% 20.0¢ cynata therapeutics limited

Screenshot(s) from Annual Report of 29 Aug 24, page-19

  1. 842 Posts.
    lightbulb Created with Sketch. 340
    Just for fun, here is the performance of those 5 companies since their Annual Reports were released with the 'Going Concern' matters raised:
    Ticker (ASX) Price at Annual Report ReleaseCurrent PriceStock Performance
    1ATX0.0890.12540.4%
    2SNT0.040.035-12.5%
    3MSB0.951.0712.6%
    4NEU1.4514.28884.8%
    5ACW0.0250.03956.0%
    https://hotcopper.com.au/data/attachments/6429/6429657-2b485f4971e59e99909182e8f1072c83.jpg


    From memory, it is the first time we have seen this on a Cynata Annual Report. But the auditors do have specific responsibilities and open themselves to unlimited liability should they not identify key business risks to shareholders: https://treasury.gov.au/publication/clerp-paper-no-9-proposals-for-reform-corporate-disclosure/part-5-auditor-liability

    This killed Arthur Anderson - a multi-billion dollar partnership.

    Our net loss in FY2024 is greater than the cash at 30 June 2024. If the auditor had reviewed this and not outlined the need for additional capital this financial year, they would have rocks in their head. I know the company is keen to say "we have a cash runway through to H2 2025," but they would be insane to leave a capital raising until next FY (because of time-pressure putting pressure on the overall raise price etc.) in the absence of other revenue coming in (be it via the options being exercised in April 2025, or a commercial licence deal).
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
(20min delay)
Last
20.0¢
Change
-0.005(2.44%)
Mkt cap ! $36.11M
Open High Low Value Volume
19.0¢ 20.0¢ 19.0¢ $19.42K 101.9K

Buyers (Bids)

No. Vol. Price($)
1 8208 19.5¢
 

Sellers (Offers)

Price($) Vol. No.
20.0¢ 9829 1
View Market Depth
Last trade - 15.42pm 03/09/2024 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.